PTCT icon

PTC Therapeutics
PTCT

Overview Fund Activity

201 hedge funds and large institutions have $3.81B invested in PTC Therapeutics in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 78 increasing their positions, 73 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
–
Holders Change %
0%
% of All Funds
3.22%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
29
Increased
78
Reduced
73
Closed
27
Calls
$15.7M
Puts
$10.1M
Net Calls
+$5.69M
Net Calls Change
-$3.95M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$89.5M
2
RI
RTW Investments
New York
$344M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$155M
4
SI
Sofinnova Investments
California
$25M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$83.2M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$464M
2
State Street
State Street
Massachusetts
$141M
3
AC
Armistice Capital
New York
$142M
4
Wellington Management Group
Wellington Management Group
Massachusetts
$339M
5
BlackRock
BlackRock
New York
$304M
Name Holding Trade Value Shares
Change 		Shares
Change %
EC
226
Elequin Capital
New York
– -$611 -16 Closed
MSCM
227
McElhenny Sheffield Capital Management
Texas
– -$611 -16 Closed
6 7 8 9
10